Dupont Jakob
SEC insider (Form 3/4/5 filer). CIK 0001553335. Director at Pyxis Oncology, Inc. (PYXS) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in BOSTON, MA.
Companies Dupont Jakob has filed insider reports for
- Pyxis Oncology, Inc. (PYXS): Director
- Bolt Biotherapeutics, Inc. (BOLT): Director
Dupont Jakob
CIK: 0001553335
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Aug 20, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
46K shares- - Jun 30, 2026PYXS
Pyxis Oncology, Inc.
SaleDirect35K shares at avg. $3.06$107K - Jun 30, 2026PYXS
Pyxis Oncology, Inc.
ExerciseDirect35K shares at avg. $1.60$56K - Jun 10, 2026BOLT
Bolt Biotherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5K shares- - Mar 24, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
45.9K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
DispositionDirectDirector Stock Option (Right to Buy)
1.1K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
849 shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
DispositionDirectDirector Stock Option (Right to Buy)
849 shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
1K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
DispositionDirectDirector Stock Option (Right to Buy)
1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 20, 2026 |  PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 46,000 | - | - | Direct |
| Jun 30, 2026 | PYXS Pyxis Oncology, Inc. | Sale | 35,000 | $3.06 | $107,100 | Direct |
| Jun 30, 2026 | PYXS Pyxis Oncology, Inc. | Exercise | 35,000 | $1.60 | $56,000 | Direct |
| Jun 10, 2026 |  BOLT Bolt Biotherapeutics, Inc. | Award Stock Option (Right to Buy) | 5,000 | - | - | Direct |
| Mar 24, 2026 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 45,867 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition Director Stock Option (Right to Buy) | 1,100 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award Director Stock Option (Right to Buy) | 849 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition Director Stock Option (Right to Buy) | 849 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award Director Stock Option (Right to Buy) | 1,000 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition Director Stock Option (Right to Buy) | 1,000 | - | - | Direct |
1-10 of 18 transactions